Table: begin end state 1 36 cytoplasmic 37 55 transmembrane 56 63 non-cytoplasmic 64 86 transmembrane 87 97 cytoplasmic 98 117 transmembrane 118 123 non-cytoplasmic 124 146 transmembrane 147 163 cytoplasmic 164 185 transmembrane 186 196 non-cytoplasmic 197 216 transmembrane 217 255 cytoplasmic 256 278 transmembrane 279 284 non-cytoplasmic 285 304 transmembrane 305 315 cytoplasmic 316 333 transmembrane 334 338 non-cytoplasmic 339 360 transmembrane 361 384 cytoplasmic 385 405 transmembrane 406 410 non-cytoplasmic 411 430 transmembrane 431 452 cytoplasmic
Input: >BPHYT_RS30290 FitnessBrowser__BFirm:BPHYT_RS30290 MNSDATAALTSLTATRPTSKVRRAVTTAVLGQVLEWYDFFLYGTAAALVFGKLFFPVGSD PLTGTIAAFGGFTVGFIARPIGGVLCGHIGDRYGRKTVMMLTLLVMGTATVCMGLLPTYQ QVGIAAPIMLVLLRVLQGLAAGGEWSGSILLIHESAPASRRGALAAWSPCGAAFGFVLST AAFLLVQTLSPADFHSWGWRVPFLCSAALVALGLWMRRSVDESAEFAAVKATHRDARMPV VEVLRQCPRQVLTVFGLRFGEGAASYIFFAFSIAYGQFIGLKSSWVLGGLTVSMLLMIPV SLLMGRLTDRVGRKPVYLAGAVAMVLVAYPYFTLLGSGVLWKVITALVLANSITLGILEG AQPAFISELLPVHLRFSGLGIGREISSVLGGGLSPMVATALLAHYRSAAPVAIYLVVLGL ITVIATCLAPETFPKALRLQAKAKEHAGHESV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server